Japan Researchers Fears Loss Of Public Trust After Novartis Trial Scandal
This article was originally published in PharmAsia News
Executive Summary
Japan's drug researchers are voicing concerns the scandal surrounding a Novartis Pharma K.K. employee who may have skewed results of at least four clinical-trial results will create a reputation tarnishing their work as well.